{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:43:11Z","timestamp":1791430991340,"version":"4.3.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41440-018-0165-7","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T07:30:01Z","timestamp":1544772601000},"page":"717-729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial"],"prefix":"10.1038","volume":"42","author":[{"given":"Hua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"165_CR1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Standards for ReportIng Vascular changes on nEuroimaging (STRIVEv1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822\u201338.","journal-title":"Lancet Neurol"},{"key":"165_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.288.1.67","volume":"288","author":"TY Wong","year":"2002","unstructured":"Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP. et al., ARIC Investigators Atherosclerosis Risk in Communities Study. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA. 2002;288:67\u201374.","journal-title":"JAMA"},{"key":"165_CR3","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/STROKEAHA.111.648576","volume":"43","author":"R Weber","year":"2012","unstructured":"Weber R, Weimar C, Blatchford J, Hermansson K, Wanke I, M\u00f6ller-Hartmann C, et al. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) MRI substudy. Stroke. 2012;43:2336\u201342.","journal-title":"Stroke"},{"key":"165_CR4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/WNL.0b013e3182661f2b","volume":"79","author":"LC Silbert","year":"2012","unstructured":"Silbert LC, Dodge HH, Perkins LG, Sherbakov L, Lahna D, Erten-Lyons D, et al. Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology. 2012;79:741\u201347.","journal-title":"Neurology"},{"key":"165_CR5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/hr.2015.135","volume":"39","author":"Z Liu","year":"2016","unstructured":"Liu Z, Zhao Y, Zhang H, Chai Q, Cui Y, Diao Y, et al. Excessive variability in systolic blood pressure that is self-measured at home exacerbates the progression of brain white matter lesions and cognitive impairment in the oldest old. Hypertens Res. 2016;39:245\u201353.","journal-title":"Hypertens Res"},{"key":"165_CR6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00415-006-0238-4","volume":"254","author":"MJ Firbank","year":"2007","unstructured":"Firbank MJ, Wiseman RM, Burton EJ, Saxby BK, O\u2019Brien JT, Ford GA. Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol. 2007;254:713\u201321.","journal-title":"J Neurol"},{"key":"165_CR7","doi-asserted-by":"crossref","first-page":"c3666","DOI":"10.1136\/bmj.c3666","volume":"341","author":"S Debette","year":"2010","unstructured":"Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.","journal-title":"BMJ"},{"key":"165_CR8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689\u2013701.","journal-title":"Lancet Neurol"},{"key":"165_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fphar.2016.00061","volume":"7","author":"TM Silva De","year":"2016","unstructured":"De Silva TM, Miller AA. Cerebral small vessel disease: targeting oxidative stress as a novel therapeutic strategy? Front Pharmacol. 2016;7:61.","journal-title":"Front Pharmacol"},{"key":"165_CR10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","volume":"11","author":"M Baumgart","year":"2015","unstructured":"Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11:718\u201326.","journal-title":"Alzheimers Dement"},{"key":"165_CR11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13195-017-0262-x","volume":"9","author":"JM Gabin","year":"2017","unstructured":"Gabin JM, Tambs K, Saltvedt I, Sund E, Holmen J. Association between blood pressure and Alzheimer disease measured up to 27 years prior to diagnosis: the HUNT Study. Alzheimers Res Ther. 2017;9:37.","journal-title":"Alzheimers Res Ther"},{"key":"165_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2014.06.011","volume":"11","author":"M Groot de","year":"2015","unstructured":"de Groot M, Ikram MA, Akoudad S, Krestin GP, Hofman A, van der Lugt A, et al. Tract-specific white matter degeneration in aging: the Rotterdam Study. Alzheimers Dement. 2015;11:321\u201330.","journal-title":"Alzheimers Dement"},{"key":"165_CR13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/ageing\/afs166","volume":"42","author":"A Dregan","year":"2013","unstructured":"Dregan A, Stewart R, Gulliford MC. Cardiovascular risk factors and cognitive decline in adults age 50 and over: a population-based cohort study. Age Ageing. 2013;42:338\u201345.","journal-title":"Age Ageing"},{"key":"165_CR14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCULATIONAHA.110.961052","volume":"123","author":"O Godin","year":"2011","unstructured":"Godin O, Tzourio C, Maillard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation. 2011;123:266\u201373.","journal-title":"Circulation"},{"key":"165_CR15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/awf077","volume":"125","author":"FE Leeuw","year":"2002","unstructured":"Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain. 2002;125:765\u201372.","journal-title":"Brain"},{"key":"165_CR16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jamda.2014.07.005","volume":"15","author":"J Peng","year":"2014","unstructured":"Peng J, Lu F, Wang Z, Zhong M, Sun L, Hu N, et al. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study. J Am Med Dir Assoc. 2014;15:904\u201310.","journal-title":"J Am Med Dir Assoc"},{"key":"165_CR17","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.14930","volume":"316","author":"K Bibbins-Domingo","year":"2016","unstructured":"US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, Garc\u00eda FA, et al. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316:1997\u20132007.","journal-title":"JAMA"},{"key":"165_CR18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/M17-0681","volume":"168","author":"MB Mortensen","year":"2018","unstructured":"Mortensen MB, Nordestgaard BG. Comparison of five major guidelines for statin use in primary prevention in a contemporary general population. Ann Intern Med. 2018;168:85\u201392.","journal-title":"Ann Intern Med"},{"key":"165_CR19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483\u201397.","journal-title":"Lancet Neurol"},{"key":"165_CR20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00002512-200118030-00007","volume":"18","author":"S Neldam","year":"2001","unstructured":"Neldam S, Forsen B, Multicentre Study Group. Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazide. Drugs Aging. 2001;18:225\u201332.","journal-title":"Drugs Aging"},{"key":"165_CR21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3233\/JAD-170238","volume":"59","author":"JD Edwards","year":"2017","unstructured":"Edwards JD, Ramirez J, Callahan BL, Tobe SW, Oh P, Berezuk C, et al. Alzheimer\u2019s Disease Neuroimagine initiative. Antihypertensive treatment is associated with MRI-derived markers of neurodegeneration and impaired cognition: a propensity-weighted cohort study. J Alzheimers Dis. 2017;59:1113\u201322.","journal-title":"J Alzheimers Dis"},{"key":"165_CR22","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/STROKEAHA.110.583948","volume":"41","author":"K Washida","year":"2010","unstructured":"Washida K, Ihara M, Nishio K, Fujita Y, Maki T, Yamada M, et al. Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-\u03b3 activation in mice with chronic cerebral hypoperfusion. Stroke. 2010;41:1798\u2013806.","journal-title":"Stroke"},{"key":"165_CR23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","volume":"7","author":"HC Diener","year":"2008","unstructured":"Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Stroke (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008;7:875\u201384.","journal-title":"Lancet Neurol"},{"key":"165_CR24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2013.12.004","volume":"233","author":"Z Liu","year":"2014","unstructured":"Liu Z, Zhao Y, Wei F, Ye L, Lu F, Zhang H, et al. Treatment with telmisartan\/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17\/Treg functional imbalance in hypertensive patients with carotid atherosclerosis. Atherosclerosis. 2014;233:291\u20139.","journal-title":"Atherosclerosis"},{"key":"165_CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2016.3783","volume":"74","author":"JM Zissimopoulos","year":"2017","unstructured":"Zissimopoulos JM, Barthold D, Brinton RD, Joyce G. Sex and race differences in the association between statin use and the incidence of Alzheimer disease. JAMA Neurol. 2017;74:225\u201332.","journal-title":"JAMA Neurol"},{"key":"165_CR26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-017-0237-y","volume":"9","author":"N Geifman","year":"2017","unstructured":"Geifman N, Brinton RD, Kennedy RE, Schneider LS, Butte AJ. Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer\u2019s disease. Alzheimers Res Ther. 2017;9:10.","journal-title":"Alzheimers Res Ther"},{"key":"165_CR27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00415-009-5008-7","volume":"256","author":"VC Mok","year":"2009","unstructured":"Mok VC, Lam WW, Fan YH, Wong A, Ng PW, Tsoi TH, et al. Effects of statins on the progression of cerebral white matter lesion: post hoc analysis of the ROCAS (Regression Of Cerebral Artery Stenosis) study. J Neurol. 2009;256:750\u201357.","journal-title":"J Neurol"},{"key":"165_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000313614","volume":"30","author":"JH Fu","year":"2010","unstructured":"Fu JH, Mok V, Lam W, Wong A, Chu W, Xiong Y, et al. Effects of statins on progression of subclinical brain infarct. Cerebrovasc Dis. 2010;30:51\u201356.","journal-title":"Cerebrovasc Dis"},{"key":"165_CR29","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/STROKEAHA.108.540088","volume":"40","author":"PC Lavall\u00e9e","year":"2009","unstructured":"Lavall\u00e9e PC, Labreuche J, Gongora-Rivera F, Jaramillo A, Brenner D, Klein IF. et al., Lacunar-BICHAT Investigators Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. Stroke. 2009;40:1721\u20138.","journal-title":"Stroke"},{"issue":"11","key":"165_CR30","first-page":"995-1002.e4","volume":"19","author":"Tiantian Ji","year":"2018","unstructured":"Ji T, Zhao Y, Wang J, Cui Y, Duan D, Chai Q, et al. Effect of low-dose statins and apolipoprotein E genotype on cerebral small vessel disease in older hypertensive patients: a subgroup analysis of a randomized clinical trial. J Am Med Dir Assoc. 2018;19:995\u20131002.","journal-title":"Journal of the American Medical Directors Association"},{"key":"165_CR31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341\u201355.","journal-title":"Neuron"},{"issue":"Suppl 1","key":"165_CR32","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","volume":"23","author":"S Smith","year":"2004","unstructured":"Smith S, Jenkinson M, Woolrich M, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23(Suppl 1):S208\u2013S219.","journal-title":"Neuroimage"},{"key":"165_CR33","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. Fsl. Neuroimage. 2012;62:782\u201390.","journal-title":"Neuroimage"},{"key":"165_CR34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaneurol.2014.754","volume":"71","author":"MI Kester","year":"2014","unstructured":"Kester MI, Goos JD, Teunissen CE, Benedictus MR, Bouwman FH, Wattjes MP, et al. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. JAMA Neurol. 2014;71:855\u201362.","journal-title":"JAMA Neurol"},{"key":"165_CR35","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/CIRCULATIONAHA.111.037036","volume":"124","author":"WB White","year":"2011","unstructured":"White WB, Wolfson L, Wakefield DB, Hall CB, Campbell P, Moscufo N, et al. Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Circulation. 2011;124:2312\u20139.","journal-title":"Circulation"},{"key":"165_CR36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(00)02628-3","volume":"356","author":"K Yaffe","year":"2000","unstructured":"Yaffe K, Lui LY, Grady D, Cauley J, Kramer J, Cummings SR. Cognitive decline in women in relation to non-protein-bound oestradiol concentriations. Lancet. 2000;356:708\u201312.","journal-title":"Lancet"},{"key":"165_CR37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","volume":"163","author":"C Tzourio","year":"2003","unstructured":"Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, Chalmers J, The PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069\u201375.","journal-title":"Arch Intern Med"},{"key":"165_CR38","volume-title":"Mental Status Examination for organic mental syndrome in the elderly patient","author":"S Mattis","year":"1988","unstructured":"Mattis S. Mental Status Examination for organic mental syndrome in the elderly patient. New York: Grune & Stratton Inc; 1988."},{"key":"165_CR39","unstructured":"Pocock SJ. Clinical trials: a practical approach. 1st ed. Chichester: Wiley; 1983. p. 123\u201341."},{"key":"165_CR40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2016.02.003","volume":"247","author":"Z Liu","year":"2016","unstructured":"Liu Z, Zhao Y, Wang X, Zhang H, Cui Y, Diao Y, et al. Low carotid artery wall shear stress is independently associated with brain white-matter hyperintensities and cognitive impairment in older patients. Atherosclerosis. 2016;247:78\u201386.","journal-title":"Atherosclerosis"},{"key":"165_CR41","volume":"7","author":"D Duan","year":"2017","unstructured":"Duan D, Dong Y, Zhang H, Zhao Y, Diao Y, Cui Y, et al. Empty-nest-related psychological distress is associated with progression of brain white matter lesions and cognitive impairment in the elderly. Sci Rep. 2017;7:43816.","journal-title":"Sci Rep"},{"key":"165_CR42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/STROKEAHA.109.563502","volume":"41","author":"J Jimenez-Conde","year":"2010","unstructured":"Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, Sonni S, et al. Hyperlipidemia and reduced white matter hyperintensity volume in patient with ischemic stroke. Stroke. 2010;41:437\u2013442.","journal-title":"Stroke"},{"key":"165_CR43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.STR.0000149625.99732.69","volume":"36","author":"WT Longstreth Jr","year":"2005","unstructured":"Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, Manolio TA, Lefkowitz D, Jungreis C, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke. 2005;36:56\u201361.","journal-title":"Stroke"},{"key":"165_CR44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrneurol.2010.70","volume":"6","author":"JR Warsch","year":"2010","unstructured":"Warsch JR, Wright CB. Stroke: hyperlipidemia and cerebral small-vessel disease. Nat Rev Neurol. 2010;6:307\u20138.","journal-title":"Nat Rev Neurol"},{"key":"165_CR45","doi-asserted-by":"crossref","first-page":"235709","DOI":"10.1155\/2015\/235709","volume":"2015","author":"M Jani\u0107","year":"2015","unstructured":"Jani\u0107 M, Lunder M, \u0160abovi\u010d M. A low-dose combination of fluvastatin and valsartan: a new \u201cdrug\u201d and a new approach for decreasing the arterial age. Biomed Res Int. 2015;2015:235709.","journal-title":"Biomed Res Int"},{"key":"165_CR46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2014.09.027","volume":"743","author":"M Jani\u0107","year":"2014","unstructured":"Jani\u0107 M, Lunder M, Zupan J, \u010cerne D, Marc J, Dreven\u0161ek G, et al. The low-dose atorvastatin and valsartan combination effectively protects the arterial wall from atherogenic diet-induced impairment in the guinear pig. Eur J Pharmacol. 2014;743:31\u201336.","journal-title":"Eur J Pharmacol"},{"key":"165_CR47","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1161\/CIRCULATIONAHA.105.557652","volume":"111","author":"SM Grundy","year":"2005","unstructured":"Grundy SM. The issue of statin safety: where do we stand? Circulation. 2005;111:3016\u20139.","journal-title":"Circulation"},{"key":"165_CR48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5414\/CN107943","volume":"80","author":"M Mu\u00f1oz-Cort\u00e9s","year":"2013","unstructured":"Mu\u00f1oz-Cort\u00e9s M, Cabr\u00e9 C, Villa D, Vives JP, Arruche M, Soler J, et al. Oxidative stress and other risk factors for white matter lesions in chronic hemodialysis patients. Clin Nephrol. 2013;80:187\u2013197.","journal-title":"Clin Nephrol"},{"key":"165_CR49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5114\/aoms.2013.33357","volume":"9","author":"CV Rizos","year":"2013","unstructured":"Rizos CV, Liberopoulos EN, Tellis CC, Tselepis AD, Elisaf MS. The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-\u03b3 activating capacity on plasma 8-isoprostane prostaglandin F2a levels. Arch Med Sci. 2013;9:172\u20136.","journal-title":"Arch Med Sci"},{"key":"165_CR50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0735-1097(02)02030-2","volume":"40","author":"RC Pasternak","year":"2002","unstructured":"Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C. American College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute. ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002;40:567\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"165_CR51","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/STROKEAHA.116.012532","volume":"47","author":"PS Sachdev","year":"2016","unstructured":"Sachdev PS, Thalamuthu A, Mather KA, Ames D, Wright MJ, Wen W, OATS Collaborative Research Team. White matter hyperintensities are under strong genetic influence. Stroke. 2016;47:1422\u20138.","journal-title":"Stroke"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0165-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0165-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0165-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:19:58Z","timestamp":1684617598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-018-0165-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["165"],"URL":"https:\/\/doi.org\/10.1038\/s41440-018-0165-7","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,14]]},"assertion":[{"value":"23 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}